Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

FIGUEROA, ANTONIO

NPI: 1376596080 · BROWNSVILLE, TX 78520 · Pediatrics Physician · NPI assigned 05/17/2006

$1.84M
Total Medicaid Paid
108,310
Total Claims
72,927
Beneficiaries
53
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 29 $1K
2020 8,011 $43K
2021 28,500 $349K
2022 29,253 $561K
2023 25,787 $521K
2024 16,730 $360K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 30,796 19,633 $569K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 5,343 4,571 $214K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2,628 2,110 $153K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2,672 2,104 $149K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2,585 2,047 $144K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,064 1,587 $105K
90460 Immunization administration through 18 years of age via any route, first or only component 13,638 5,300 $93K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 8,768 7,186 $90K
87428 1,082 970 $75K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 6,980 3,064 $75K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,516 1,358 $64K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 10,644 8,295 $44K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2,246 1,646 $14K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 230 199 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,118 961 $7K
96110 Developmental screening, with scoring and documentation, per standardized instrument 1,144 696 $5K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,380 903 $5K
0071A 145 120 $4K
0072A 90 77 $3K
99000 498 418 $3K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 82 60 $2K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 44 28 $2K
86580 218 178 $1K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 102 87 $858.60
83655 151 77 $710.77
0081A 26 20 $680.00
81002 348 301 $607.55
0083A 20 18 $400.00
92567 31 28 $363.05
J0696 Injection, ceftriaxone sodium, per 250 mg 744 599 $197.43
90688 917 628 $170.88
90658 1,213 1,055 $36.92
97802 267 233 $30.31
90670 1,804 1,406 $0.02
90680 1,029 783 $0.01
90648 826 646 $0.01
90657 168 140 $0.00
36415 Collection of venous blood by venipuncture 438 307 $0.00
90698 452 343 $0.00
90723 98 79 $0.00
90696 97 56 $0.00
G9716 Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason 50 49 $0.00
91307 243 177 $0.00
36416 179 89 $0.00
90633 801 590 $0.00
90707 397 369 $0.00
90700 318 246 $0.00
90734 439 348 $0.00
90649 422 255 $0.00
90687 346 205 $0.00
90710 366 205 $0.00
91308 28 20 $0.00
90715 79 57 $0.00